 |
| from Wikipedia |
Poor responders to Bevacizumab (Avastin) in patients with age-related macular degeneration (AMD) and diabetic macular edema (DME) may have increased risk to obstructive sleep apnea (OSA).
Showing posts with label Apnea. Show all posts
Showing posts with label Apnea. Show all posts
Friday, January 2, 2015
Poor Avastin responders in AMD & DME may have increased risk to obstructive sleep apnea
Poor responders to Bevacizumab (Avastin) in patients with age-related macular degeneration (AMD) and diabetic macular edema (DME) may have increased risk to obstructive sleep apnea (OSA).
Subscribe to:
Posts (Atom)